We have a fix for obesity, but only the wealthy can afford the new weight loss drugs
Modern medicine has, at last, developed the means to change the course of one of the great epidemics of our age, yet the fruits of that success remain within reach only for those who can afford them. The arrival of GLP-1 receptor agonists such as semaglutide and tirzepatide has transformed weight loss from an unreliable … Read more